$3.14
0.082.61%
Últ. Act.: Oct 30, 4:00 PM
Lexeo Therapeutics (LXEO) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.28 | $-0.30 | $-0.31 | $-0.46 |
| Actual | $-0.30 | $-0.25 | $-0.27 | $-0.33 |
| Surprise | -7.14% | +16.7% | +12.9% | +28.3% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | — |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.32 | $-0.34 | $-0.32 | $-0.34 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 12, 2026 | $-0.30 | $-0.28 | -7.14 % |
| Q1 | May 11, 2026 | $-0.25 | $-0.30 | 16.7 % |
| Q4 | Mar 30, 2026 | $-0.27 | $-0.31 | 12.9 % |
| Q3 | Nov 5, 2025 | $-0.33 | $-0.46 | 28.3 % |